«Smart» hydrogel nanocomposites for biomedical applications

Authors

  • Yu. M. Samchenko F. D. Ovcharenko Institute of Biocolloid Chemistry, NAS of Ukraine 42, Akademika Vernadskoho Blvd., Kyiv, Ukraine, 03142 Author
  • A. P. Maletsky Filatov Institute of eye diseases and tissue therapy, NAMS of Ukraine 49/51, Francuzsky Blvd., Odessa, Ukraine, 65006 Author
  • L. O. Kernosenko F. D. Ovcharenko Institute of Biocolloid Chemistry, NAS of Ukraine 42, Akademika Vernadskoho Blvd., Kyiv, Ukraine, 03142 Author
  • O. A. Samoylenko R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiology, NAS of Ukraine 45, Vasylkivska Str., Kyiv, Ukraine, 03022 Author
  • I. I. Ganusevich R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiology, NAS of Ukraine 45, Vasylkivska Str., Kyiv, Ukraine, 03022 Author
  • S. M. Dybkova F. D. Ovcharenko Institute of Biocolloid Chemistry, NAS of Ukraine 42, Akademika Vernadskoho Blvd., Kyiv, Ukraine, 03142 Author

DOI:

https://doi.org/10.7124/bc.000AD6

Keywords:

hydrogels, endoprostheses, diagnosis of cancer, Albucid, Doxorubicin

Abstract

Aim. Application of polymer composites based hydrogels filled by functionalized nanoparticles (acid-modified nanoclay laponite and gold nanoparticles) allows their use for early diagnosis of cancer and filling postoperative cavities, especially after tumor resection. Conclusions. Acid modification of Lap can serve as a basis for the development of the nanocomposite hydrogel diagnostic systems. The synthesized hybrid polymeric materials based on porous polyvinylformal, acrylic hydrogels and gold nanoparticles can be used to fill postoperative cavities with simultaneous targeted release of the incorporated Doxorubicin and Albucide.

Downloads

Published

2024-09-10

Issue

Section

Chronicle and Information